A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss
- 1 May 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 98 (5) , 452-458
- https://doi.org/10.1016/s0002-9343(99)80344-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical use of biochemical markers of bone remodeling in osteoporosisBone, 1992
- Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosisOsteoporosis International, 1991
- Dual photon absorptiometry of lumbar spine in West European (Belgian) postmenopausal females: normal range and fracture thresholdClinical Rheumatology, 1990
- In vitro detection of neutralizing antibodies after treatment of paget's disease of bone with nasal salmon calcitoninJournal of Bone and Mineral Research, 1990
- Influence of Specific Anti-Salmon Calcitonin Antibodies on Biological Effectiveness of Nasal Salmon Calcitonin in Paget's Disease of BoneScandinavian Journal of Rheumatology, 1990
- One year's treatment of paget's disease of bone by synthetic salmon calcitonin as a nasal sprayJournal of Bone and Mineral Research, 1988
- CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSSThe Lancet, 1988
- A Double-blind Trial of Synthetic Salmon Calcitonin in the Treatment of Acute PancreatitisScandinavian Journal of Gastroenterology, 1979
- Treatment of Paget's Disease with the Calcitonins*Australian and New Zealand Journal of Medicine, 1979
- DIAGNOSTIC PROCEDURES IN DISORDERS OF CALCIUM METABOLISMClinical Endocrinology, 1978